Pharmacia Vestra
Executive Summary
Janssen and Pharmacia terminate co-promotion agreement for anti-depressant Vestra (reboxetine). The norepinephrine reuptake inhibitor has been pending since April 1998, and was been deemed "approvable" in July 1999 and again in February 2000 (1"The Pink Sheet" Feb. 28, In Brief). Pharmacia says an additional Vestra clinical study intended to support approval is nearing completion